Viewing data from:

MIRTAZAPINE

ANDA

MIRTAZAPINE | A077376 | AUROBINDO PHARMA LTD

3 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: REMERON SOLTAB(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 6 NDCs

Highest NADAC/Unit

$0.4293

per ea

Lowest NADAC/Unit

$0.3322

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
57237001206MIRTAZAPINE 30 MG ODT	$0.4293	EA	Generic	—	2026-08-19
65862002206MIRTAZAPINE 30 MG ODT	$0.4293	EA	Generic	—	2026-08-19
57237001306MIRTAZAPINE 45 MG ODT	$0.3690	EA	Generic	—	2026-08-19
65862002306MIRTAZAPINE 45 MG ODT	$0.3690	EA	Generic	—	2026-08-19
57237001106MIRTAZAPINE 15 MG ODT	$0.3322	EA	Generic	—	2026-08-19
65862002106MIRTAZAPINE 15 MG ODT	$0.3322	EA	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain19 active DMFs4 inactive

14 active API suppliers hold Drug Master Files for this ingredient.

ASPEN OSS BVMIRTAZAPINE

DMF 104571993

TAPI NL BVMIRTAZAPINE

DMF 153232001

MEDICHEM SAMIRTAZAPINE

DMF 157492001

NEULAND LABORATORIES LTDMIRTAZAPINE

DMF 160072002

SUN PHARMACEUTICAL INDUSTRIES LTDMIRTAZAPINE USP [HEMIHYDRATE]

DMF 161132002

APITORIA PHARMA PRIVATE LTDMIRTAZAPINE ANHYDROUS USP

DMF 164902003

MATRIX PHARMACORP PRIVATE LTDMIRTAZAPINE USP (ANHYDROUS)

DMF 193692006

MEGAFINE PHARMA P LTDMIRTAZAPINE ANHYDROUS USP (NON-STERILE DRUG SUBSTANCE)

DMF 205702007

MEGAFINE PHARMA P LTDMIRTAZAPINE HEMIHYDRATE USP (NON STERILE DRUG SUBSTANCE)

DMF 230032009

NEULAND LABORATORIES LTDMIRTAZAPINE, USP (ANHYDROUS)

DMF 240222010

SYN-TECH CHEM AND PHARM CO LTDMIRTAZAPINE USP

DMF 297482015

NEULAND LABORATORIES LTDMIRTAZAPINE USP (ACETONE ROUTE)

DMF 308502016

MAITHRI DRUGS PRIVATE LTDMIRTAZAPINE USP [ROUTE CODE - MZ)

DMF 313222017

MAITHRI DRUGS PRIVATE LTDMIRTAZAPINE ANHYDROUS USP

DMF 370132022

HETERO DRUGS LTDMIRTAZAPINE

DMF 383412023

MICRO LABS LTDMIRTAZAPINE USP

DMF 387992023

MAHI DRUGS PRIVATE LTDMIRTAZAPINE USP

DMF 402032024

APITORIA PHARMA PRIVATE LTDMIRTAZAPINE USP (PROCESS-II)

DMF 413292025

ZHEJIANG LIAOYUAN PHARMACEUTICAL CO LTDMIRTAZAPINE

DMF 421602025

DIOSYNTH BVInactiveMIRTAZAPINE

DMF 83571989

SUMITOMO CHEMICAL CO LTDInactiveMIRTAZAPINE

DMF 153002001

ANGELINI ACRAF SPAInactiveMIRTAZAPINE

DMF 160142002

MYLAN LABORATORIES LTDInactiveMIRTAZAPINE USP (HEMIHYDRATE)

DMF 175212004

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (3)

Sort:

#002 — 15MG

0 patents0 exclusivities▴

TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Dec 8, 2005

No patent or exclusivity listings for this strength.

#003 — 30MG

0 patents0 exclusivities▾

TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Dec 8, 2005

#004 — 45MG

0 patents0 exclusivities▾

TABLET, ORALLY DISINTEGRATING;ORAL | Approved: Feb 28, 2006